Preserving functional capacity is a key element in the care continuum for patients with esophagogastric cancer. Prehabilitation, a preoperative conditioning intervention aiming to optimize physical status, has not been tested in upper gastrointestinal surgery to date.
E sophageal and gastric cancers are lethal tumors, with an estimated 43 300 new cases and 26 400 deaths in the United States per year. 1 Surgery, the cornerstone of curative intent treatment for localized or locally advanced esophagogastric cancers, is associated with important adverse events. 2, 3 Current best surgical practice involves the Enhanced Recovery After Surgery (ERAS) program, which has been shown to have a positive association in terms of length of hospital stay, resource use, and complications. 4, 5 Despite these advances, esophagogastric surgery is still associated with short-term and long-term adverse effects, including high rates of postoperative complications and mortality, decreased muscle strength and cardiorespiratory fitness, fatigue, depression, emotional distress, anxiety, and poor quality of life. [6] [7] [8] [9] As a result of surgical complications or impaired nutritional, physical, and performance status, most patients are not able to receive the complete sequence of neoadjuvant or adjuvant therapy. 10,11 Surgery alone is inadequate for locoregional control in patients with locally advanced disease, 12 and overall 5-year survival remains poor. 13 Therefore, optimizing perioperative functional capacity is a compelling aim in these patients. The process of enhancing physical fitness before an operation to enable the patient to withstand the stress of surgery has been termed prehabilitation.
14 The main elements are preoperative exercise and nutrition optimization. Increasing evidence indicates that prehabilitation improves perioperative physical function in major abdominal surgery. [15] [16] [17] [18] [19] Nevertheless, upper gastrointestinal surgery presents unique challenges in clinical management because of the high-risk population and treatments, and there have been few trials in this field. 20, 21 However, because physical and nutritional status are key potentially modifiable factors in esophagogastric cancer, 22, 23 prehabilitation is a notable intervention in these patients. Therefore, the objective of this randomized clinical trial was to investigate the effectiveness of prehabilitation in preventing physical decline in upper gastrointestinal surgery. We hypothesized that prehabilitation could improve functional capacity throughout the perioperative period in adults undergoing esophagogastric cancer surgery.
Methods

Trial Design
This study was a parallel-group, randomized, single-blind, pragmatic clinical trial conducted at McGill University Health Centre (Montreal, Quebec, Canada). The trial protocol (Supplement) was approved by the McGill University Health Centre Research Ethics Board, and written informed consent was obtained from each patient before randomization. Due to administrative error and oversight on the part of the principal investigator (FC), the Research Ethics Board inadvertently terminated this project in September 2016 without our notice following failure to request renewal. We had recruited most patients by then, but 6 patients were recruited after that time until February 2017. We have confirmation from the chair of the Research Ethics Board that our study was conducted according to ethical standards and we have received retroactive renewed approval through September 2017. The study was completed in July 2017.
Study Participants
Patients were assessed for eligibility at their first visit to a regional upper gastrointestinal cancer referral center within the Division of Thoracic Surgery at McGill University Health Centre. Patients were eligible for participation if they were 18 years or older and were referred electively for management of nonmetastatic esophagogastric cancer. Exclusion criteria were the following: comorbid medical, physical, and mental conditions that contraindicate exercise or oral nutrition, acute or unstable cardiac conditions (eg, unstable angina or symptomatic severe aortic stenosis), American Society of Anesthesiologists physical status classes 4 and 5, disabling orthopedic and neuromuscular disease, psychosis, dementia, cardiac failure (New York Heart Association functional classes III and IV), severe chronic obstructive pulmonary disease (forced expiratory volume in the first second of expiration <50% predicted), end-stage kidney or liver disease, anemia (symptomatic or hematocrit <30%), inability to swallow, or the presence of feeding gastrostomy or jejunostomy. Patients with poor English or French comprehension were also excluded, as were patients residing more than 50 km from Montreal General Hospital.
Study Design
Eligible patients were assigned in a 1:1 ratio to either prehabilitation or a control group. Participants were randomized using computer-generated blocks of 4, and group assignments were placed in sequentially numbered opaque envelopes. The main investigator (F.C.), assessor (R.A.), and statistician (A.V.R.) were unaware of the group assignments. Because of the nature of the intervention, it was not possible to mask participants or health care professionals, such as kinesiologists or nutritionists (S.-E.L. and other nonauthors).
also been termed multimodal prehabilitation, unlike a unimodal approach that includes only exercise. 24 
Exercise Program
At baseline, all patients had an evaluation of their fitness level and functional ability in terms of walking and endurance, strength, joint mobility, and posture. A physician (E.M.M.) prescribed an individualized, home-based exercise training program 4 times per week according to guidelines provided by the American College of Sports Medicine. 25 Participants received an individual session with a kinesiologist, who demonstrated the complete training program and provided corrective feedback as necessary. 26 Aerobic exercise consisted of 30 minutes (including 5-minute warm-up and 5-minute cooldown) of moderate continuous training 3 days per week. Exercise modalities were brisk walk, jogging, or cycling depending on personal physical level and attitude. Patients were instructed by the kinesiologist to self-select the intensity to reach 12 to 13 on rated perceived exertion (range, 6-20 on the Borg Rating of Perceived Exertion Scale). 27,28 Strengthening activity, prescribed 1 day per week, consisted of 30 minutes (including 5-minute flexibility and 5-minute stretching) of 3 sets of 8 to 12 repetitions for 8 muscle groups using an elastic band as resistance (TheraBand). Resistance level was selected by the kinesiologist to reach a moderate-intensity effort, rated as 5 to 6 on a 10-point scale. 29 Participants were provided with a logbook to record all activities. The kinesiologist monitored the adherence and addressed issues or doubts by weekly telephone calls.
Nutrition Program
At the time of enrollment, participants completed a 3-day estimated food record of 2 weekdays and 1 weekend day. A dietitian (S.-E.L.) assessed dietary habits and anthropometric data to create a comprehensive status evaluation and to estimate the required amount and relative proportion of macronutrients. 30 Metabolic requirement was adjusted to meet the increased nutritional demand due to the stress associated with their upcoming surgery. 31, 32 Food-based dietary advice was given, and whey protein supplement (Immunocal; Immunotec Inc) was prescribed to guarantee a daily protein intake of 1.2 to 1.5 g/kg of ideal body weight (or approximately 20% of total energy requirements). 33 These supplements, if needed, were consumed every morning after breakfast or immediately after exercise during training days. Nutrition therapy was given to all participants in the intervention group, even in the absence of malnutrition. 34 Participants were provided with a logbook, and the nutritionist monitored the adherence and addressed issues or doubts by weekly telephone calls.
Usual Care
All participants received standardized perioperative care according to the ERAS Society Guideline protocol, 4, 5 which is based on a clinical program implemented at our institution since 2008. The main elements include a minimally invasive surgical approach when feasible, epidural analgesia, limited use and duration of drains, minimized blood loss and perioperative fluid administration, avoidance of preoperative overnight fasting, early oral nutrition, respiratory physiotherapy, and early mobilization. The standard preoperative pathway at our institution includes risk assessment, medication management, perioperative blood management, and smoking cessation. At the time of initial visit to the upper gastrointestinal cancer referral center, all patients received nutritional counseling to plan adequate caloric provision and address specific nutritional or dysphagic disorders. Neoadjuvant chemotherapy with a docetaxel-based triplet was the preferred approach for locally advanced adenocarcinoma (cT3 or N+) based on the results of a local institutional phase 2 trial. 35 Patients with locally advanced squamous cell carcinoma tended to be offered neoadjuvant chemoradiotherapy. A multidisciplinary tumor board (L.E.F. and other nonauthors) defined personalized oncologic treatment, establishing specific indication, timing, regimen, and strategy according to patient performance status and tumor characteristics. Patients were referred for psychosocial counseling, if needed. The control group was treated according to conventional care. They received no specific intervention before surgery.
Outcomes
Measurements were recorded at 3 times in all participants. These included at baseline (beginning of the prehabilitation period for the intervention group), immediately before surgery (end of the prehabilitation period for the intervention group), and after surgery (4-8 weeks after surgery).
The primary outcome was change in functional capacity over time, measured as the difference in absolute change in 6-minute walk distance (6MWD) between baseline and the preoperative visit (primary analysis) and between baseline and the postoperative visit. A significant change was defined as an improvement or a deterioration of 20 m from baseline. 36 Participants, who were advised to wear comfortable shoes, were instructed to walk back and forth in a 20-m stretch of hallway for 6 minutes at a pace that would make them tired by the end of the walk. A masked assessor (R.A.) supervised all tests, following a standardized procedure to minimize potential sources of error due to bias or different levels of encouragement. ), length of hospital stay, 30-day hospital visits, readmission rate, death, and full adherence to the planned neoadjuvant chemotherapy. Compliance was evaluated, integrating both exercise (number of weekly training sessions completed) and nutrition (adherence to the prescribed protein supplementation).
Statistical Analysis
Because there were no data on the effect of prehabilitation for upper gastrointestinal surgery, we used an estimation based on previous trials in colorectal cancer. 45, 46 According to these data, patients who were randomly assigned to the control group were expected to decrease their 6MWD by a mean (SD) of 15 (66) m below baseline after surgery. In the intervention group, patients were expected to increase a mean (SD) of 37 (68) for categorical variables, and data are presented as the number (percentage). Analyses of the primary outcome were performed among all patients who had complete follow-up, defined as the presence of a preoperative assessment. The trial was an available-case analysis based on completed assessments. For the primary outcome, we analyzed differences between groups at all follow-up times (baseline, preoperative, and postoperative) using a mixed-model analysis of variance for repeated measurement. Secondary outcomes were compared using standard 2-sample t tests. All tests were 2 sided, and the level of significance was P = .05, unlike for repeatedmeasures analysis, in which a Bonferroni-corrected level of significance was applied. We used a software program (SPSS, version 23.0; IBM) for all statistical analyses.
Results
Patient Characteristics
Between February 13, 2013, and February 10, 2017, a total of 222 consecutive patients referred with esophagogastric cancer to the upper gastrointestinal cancer referral center at our institution were assessed for eligibility. Sixty-eight patients (31%) provided informed consent, and 51 patients (23%) were included in the primary analysis ( Figure 1) . Baseline characteristics and surgical variables were broadly similar between the 2 groups ( Table 1) . Eleven participants (22%) missed the postoperative assessment (3 in the prehabilitation group and 8 in the control group): among the 11 patients, 3 (2 prehabilitation and 1 control) had severe complications (length of hospital stay >30 days), 2 (both control) died (1 of intraoperative cardiac arrest and 1 of chyle leak), and 6 (1 prehabilitation and 5 control) failed to attend the postoperative assessment (because of weakness).
The median length of prehabilitation was 36 days (IQR, 17-73 days), and the median length of the preoperative period in the control group was 51 days (IQR, 12-71 days) (P = .88). Twenty participants (77%) had prehabilitation during neoadjuvant chemotherapy, 11 of whom (55%) started prehabilitation before medical treatment. Overall compliance with prehabilitation was 63%, and no exerciserelated adverse events were reported.
Primary Outcome
A statistically significant difference in walking distance change was observed between groups both at the preoperative assessment (mean [SD] (Figure 2) . A significant difference was also observed in the total 6MWD covered over time and in the proportion of patients who experienced a significant change in functional capacity ( Table 2) .
Secondary Outcomes
Two patients included in the primary analysis had their surgery canceled and are represented as missing data for surgical outcomes. There were no statistically significant differences between groups in terms of number and severity of complications, length of hospital stay, emergency department visits, or readmission rates ( Table 3) . Two patients in each group did not receive the full planned neoadjuvant chemotherapy (8% in the prehabilitation group vs 8% in the control group, P > .99). of multidisciplinary interventions aiming to optimize cardiorespiratory fitness in this field. 47, 48 Most studies have investigated the safety and efficacy of exercise therapy after the completion of cancer therapy. 49 Once detrimental effects of a treatment have been experienced, patients generally will need an intervention to restore the pretreatment physical status or obtain a faster recovery. The concept of rehabilitation in oncologic surgery is applied to the postoperative period. Unlike this traditional approach, the purpose of prehabilitation is to prevent, rather than cure, functional consequences of cancer therapy by addressing modifiable risk factors, such as fitness and nutrition. Aiming to increase the quality of perioperative care by accelerating recovery, prehabilitation is mandated in the ERAS pathway and represents its clinical and scientific development.
26
To our knowledge, this is the first demonstration that a structured preoperative conditioning intervention is feasible, safe, and efficacious for preventing functional impairment before and after surgical treatment for upper gastrointestinal cancer. Sixty-two percent (16 of 26) of the patients herein improved before surgery, and the positive effect was maintained after surgery in more than half of the population. Conversely, as shown in a previous study, 6 patients assigned to a control group had a decline in cardiopulmonary fitness that did not reverse and further deteriorated in the recovery period after surgery. No exercise-related adverse events were reported in the present randomized clinical trial, and the adherence rate was comparable to that in a previous study.
50
Compliance is an arduous outcome of behavioral interventions in patients with cancer and is a unique challenge in esophagogastric cancer care. Plausible explanations may be the low physical fitness of this particular population, their comorbidities, and the high rate of neoadjuvant therapy (77% [20 of 26] in the intervention group), carrying significant functional impairment. Owing to the pragmatic nature of our trial, there were no restrictions on the duration of the program, and we used the entire period from referral to surgery. Because our randomized clinical trial is the first study to date to our knowledge on prehabilitation in this population, evidence of effectiveness was lacking; therefore, we decided not to alter timing or modality of cancer treatment planned by the multidisciplinary tumor board. Nonetheless, the median length of prehabilitation was 36 days, a reasonable training period compared with other surgical settings. 51 The present trial was not powered to determine whether the difference in physical fitness was associated with fewer complications, and the morbidity rate and length of hospital stay were comparable to local and international reports at other high-volume centers.
52
Because cancer and its treatments frequently lead to disability and financial burden, 24 our findings may have several implications. Treatment-related fatigue is a common adverse effect, affecting up to 90% of patients undergoing radiotherapy and up to 80% of patients receiving chemotherapy. 53,54 Surgical-related decline in physical fitness is one of the most distressing symptoms reported by patients with cancer and directly affects their ability to function in terms of activities of daily living and quality of life. 55 Because survivorship is improving, there is a growing interest in strategies aimed to ameliorate the quality of life in cancer survivors. Also problematic is physical status deterioration, with any impairment in a patient's ability to function being 
Limitations
This study has several limitations. As previously mentioned, the variability of neoadjuvant treatment in terms of duration and regimen may limit the consistency, generalizability, and applicability of our findings. In addition, the exclusion of patients who were not willing to start a physical intervention could represent a potential selection bias. The small sample size is another limitation (222 patients were assessed to recruit 68 participants), which precluded testing of secondary outcomes. The tightness of the inclusion criteria, the need for a reasonable time to intervene before surgery, and the individual commitment to exercise are possible explanations for this high rate of exclusions. Furthermore, 17% (4 of 23) of the study population experienced deterioration after surgery. Therefore, further work is required to explore in detail the optimal type, intensity, and timing of physical and nutritional intervention. Other considerations include the introduction of a supervised training session, a consistent duration of the intervention, better integration into the medical treatment, and a larger sample size.
Conclusions
This randomized clinical trial demonstrated prehabilitationinduced significant improvement in physical status among patients undergoing surgery for malignant gastroesophageal lesions. Further investigation is required to determine the optimal modality of the intervention and its effect on overall oncologic outcomes. Role of the Funder/Sponsor: The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. [1] [2] [3] [4] [5] In this issue of JAMA Surgery, Minnella and coauthors 6 report their findings from a randomized clinical trial analyzing 51 patients undergoing esophagogastric cancer resection. Prehabilitation was associated with improved preoperative and postoperative functional capacity. One notable limitation of their trial is that frail and at-risk patients were excluded. While exclusion was done to facilitate rigor of the trial, frail and at-risk patients are the patients for whom surgical care carries the greatest risk and presumably who may benefit the most. Furthermore, like most prehabilitation clinical trials, this study was not powered to detect improvements in traditional surgical outcomes, such as complication rates, length of stay, or readmissions.
This group at McGill University Health Centre (Montreal, Quebec, Canada) leads the scientific investigation of prehabilitation and has convinced many clinicians that prehabilitation benefits patients. Their present trial demonstrates that a prehabilitation program can mitigate the expected functional decline from comprehensive esophagogastric cancer care. 6 Unfortunately, the rigorous science translates poorly into the clinical realities of day-to-day care. In other words, patients are not randomized in standard practice, and physicians may intuitively prescribe prehabilitation for those patients whom they believe stand to benefit the most. In addition, it is often unrealistic to delay a patient's medical care to undergo a prehabilitation program, especially for patients with time-sensitive, surgically amenable conditions. Diverse patients, diverse stakeholders, and diverse financing strategies contribute to a complex milieu for care and impede the acceptance and implementation of prehabilitation. More pragmatic, population-based studies of prehabilitation are essential to prove its effect and drive care transformation. As the science behind prehabilitation moves forward, it is also imperative to prove the business case for prehabilitation to surgeons, payers, and hospitals. A strong business case will jump-start widespread implementation and facilitate multiinstitutional collaboration to further advance the nuanced science behind prehabilitation.
The evidence demonstrates that, at worst, prehabilitation does no harm, and it can be a transformative clinical pathway to facilitate a better life for some patients. Over the next decade, more excellent research, such as this study by Minnella and coauthors, 6 will convince us that every patient should train for surgery. 
Barberan-Garcia
Introduction
In 2010 1,700 new cases of esophageal cancer were diagnosed in Canada and approximately 1,800 people die every year from the disease. The incidence rate of esophageal adenocarcinoma has doubled in the last 20 years, and this may reflect the rising prevalence of obesity and gastro-esophageal reflux disease.
Surgical resection offers the best chance of cure of esophageal cancer although multimodal treatment including neo-adjuvant chemotherapy and chemo-radiation is often part of the standard treatment. Most of the patients (>50%) scheduled for surgical resection are over 65 years of age, most have been smokers, and present with several comorbidities. Medical and surgical complications following esophagectomy range between 20 and 60%, with pneumonia as the most common complication. The latter has been shown to represent the principal cause of death in 55% of patients. In a recent study from this institution, the introduction of an Enhanced Recovery Pathway contributed to a significant decrease in length of stay, but had no impact on the rate of postoperative morbidity (pulmonary complications accounted for 50%), implying that patient related factors might be responsible for high postoperative morbidity.
Esophagectomy, like all major surgery, is associated with a 20% to 40% reduction in physiological and functional capacity which is experienced by the patients as a higher level of fatigue for a period of up to 6-8 weeks after hospital discharge. Fatigue is manifested by muscular weakness, increased need for sleep and decreased ability to concentrate. It is correlated with preoperative health status, preoperative fatigue, weight, and grip strength, the degree of surgical trauma and intensity of metabolic response, and with postoperative deterioration. The elderly, and others with limited metabolic protein reserve, are the most susceptible to the negative effects of surgical stress. In addition a great majority of these patients undergo chemo-radiation which causes further loss of muscle mass and fatigue. ! Efforts to improve the recovery process have primarily focused on the intraoperative and post-operative periods. However, the post operative period may not be the best time to ask surgical patients to make significant changes in their care, as they are tired and concerned about perturbing the healing process as well as being depressed and anxious as they await additional treatments for their underlying condition. The preoperative period may in fact be a better time to intervene in the factors that contribute to recovery, beyond the physical, and alleviate some of the emotional distress surrounding the anticipation of surgery and the recovery process.
The process of enhancing functional capacity of the individual before an operation to enable him or her to withstand the stress of surgery has been termed prehabilitation. It has been shown that poor baseline physical performance capacity and poor nutritional status increase the risk of complications after major non cardiac surgery and prolong recovery. One would therefore assume that by preparing the patients before surgery, they would have better chance to withstand the surgical stress.
Our group, composed of anesthesiologists, surgeons, kinesiologists, nutritionists and psychologists have started a few years ago to conduct studies on prehabilitation at the Montreal General Hospital. The first and largest trial on surgical prehabilitation, compared two exercise regimens (intense exercise on a stationary bike vs walking and deep breathing) for 4-5weeks before colorectal surgery. The primary outcome was functional walking capacity measured by the six-minute walk test (6MWT) between 5 to 9 weeks postoperatively. Subgroup analysis identified that patients whose functional exercise capacity improved preoperatively, regardless of exercise technique, recovered well in the postoperative period. However, one-third of patients deteriorated preoperatively despite the exercise regimen, and these patients were also at greater risk of prolonged recovery after surgery. Poor preoperative physical function (fatigue, under/malnutrition and physical performance) and presence of anxiety and depression were also significant confounding predictors of prolonged recovery. These results suggested that exercise alone is not sufficient to attenuate the stress response in all patients. The physical and psychological deterioration observed in a subgroup of patients made us more aware of the role of nutritional status and psychological well-being in surgical recovery.
Therefore we conducted a second multimodal prehabilitation program in a group of patients scheduled for colorectal resection of cancer, based on exercise, supplemental nutrition with whey protein, and stress reduction strategies that were initiated 3-5 weeks before surgery and continued postoperatively for 8 weeks.
Functional capacity, as assessed by the 6MWT, increased in the preoperative period by an average of >40 mt, and >81% of patients were at or above their baseline measurement 8 weeks after surgery. At the end of the multimodal prehabilitation program, patients experienced more feelings of vigor and less impairment of activities.Unlike in the previous trial using exercise alone, where one third of the patients deteriorated despite prehabilitation, no patients deteriorated from baseline in this new multimodal program.
In view of these results it is appropriate to apply multimodal prehabilitation to patients affected by esophageal cancer in order to enhance the preoperative physical, nutritional and psychological capacities and hopefully impact postoperative functional capacity and morbidity.
We propose a randomized controlled study in patients undergoing esophageal resection for cancer to determine the impact of multimodal prehabilitation on functional exercise capacity and postoperative pulmonary complications. Patients who accept to be enrolled in the study will be randomized to receive either a standard nutritional intervention (including supplements as needed) as per current institution policy or standard nutritional intervention (including supplements as needed) combined with a physical exercise program before and after surgery.
Hypothesis
It is hypothesized that, compared with the group receiving nutrition alone, the addition of physical exercise to nutrition starting before surgery and continuing for 8 weeks after surgery will have a significantly greater impact on functional walking capacity during the prehabilitation period and during the postoperative period, and on the incidence of postoperative pulmonary complications.
Specific aims
The aims of this research project are the following:
1.! To determine the extent in which a multimodal prehabilitation regimen optimizes functional recovery in patients suffering from esophageal cancer and the incidence of postoperative pulmonary complications.
2.! To understand further which measures of immediate surgical recovery are sensitive to prehabilitation interventions, and predict change in later outcome measures.
Patients and Methods
Patients
The study has been submitted to the McGill University Health Centre Ethics Board for approval. Three previous studies on prehabilitation (see Background, above) were approved and completed by our team in our institution (McGill University Health Centre-Montreal General Hospital Research Ethics Committee REC#02-053, #09-284, # 011-004 ).
Subjects eligible to enter the study include those aged 18 and older who have been referred electively for resection of malignant esophageal lesion. Excluded will be persons with American Society of Anesthesiologists (ASA) health status class 4-5 or co-morbid medical, physical and mental conditions (e.g.dementia, disabling orthopedic and neuromuscular disease, psychosis), severe cardiac abnormalities, severe end-organ disease such as cardiac failure (New York Heart Association classes I-IV), COPD, renal failure (creatinine > 1.5 mg/dl, and hepatic failure ALT and AST >50% over the normal range), sepsis, morbid obesity (BMI >30), anemia (hematocrit < 30 %, haemoglobin <10g/dl, albumin < 25mg/dl). Patients will be excluded if they cannot swallow and/or are being fed through a percutaneous endoscopy gastronomy or jejunostomy tube. Patients with poor English or French comprehension will also be excluded. In order to participate in this study the patients need to have the ability to complete the questionnaire in French or English
Recruitment and multidisciplinary evaluation
At the MUHC patients with a diagnosis of esophageal cancer, and scheduled for preoperative neo-adjuvant chemotherapy (mostly docetaxel, cisplatin, and 5-FU based on the recently published results of a local phase II trial) are operated by Drs L Ferri and D Mulder, esophageal surgeons, who perform at the MUHC a total of approximately 50 esophageal cancer resections annually. Patients will be screened by the medical research team for health conditions that would prohibit participation in the program. The following are the steps taken in the recruitment: 1)! Patients scheduled for elective esophageal surgery (preceded or not by neoadjuvant chemotherapy), that also meet inclusion/exclusion criteria, will be identified and initial contact made by their surgeons at a scheduled appointment. The surgeons will introduce the study to the patients.
2)! If the patient decides he/she would like more information about the study, and is willing to be contacted by the research study coordinator, the surgeonÕs secretary will inform the study coordinator.
3)! The study coordinator will then contact the patient to explain all the details of the study. If the patient is interested in participating in the study, the coordinator will schedule a time for the patient to come in to the anesthesia lab to complete the informed consent and the preoperative assessments.
4)! When the patient arrives at the anesthesia clinic, he/she will once more receive all the study details from the coordinator and be asked to read the informed consent. Once informed consent has been obtained patients will be randomized (computer generated randomization) and the study protocol will be implemented. Patients will then have their physical, nutritional and psychological assessments conducted by a kinesiologist and a nutritionist respectively.
Hospital standards
Routine standard preoperative and postoperative clinical care at the MUHC does not include prehabilitation. Patients are usually seen by their surgeons in the clinic and they are then referred to the MUHC nutritionist for nutritional assessment and counselling/treatment. Psychological support is also provided to patients on an ad hoc basis during the treatment by the hospital psychologist. An Enhanced Recovery Program for esophagectomy has been implemented in 2010 by the SURE committee of the MUHC with a standardized perioperative pathway. All patients receive a booklet with the instructions related to the pathway detailing the preoperative, intraoperative and postoperative periods.
Study Arms
1.! Standard group
Patients in this group will follow standard MUHC protocol of nutritional counselling. This group will receive general instructions on exercises (breathing, ankle rotation) to be done during hospital stay by kinesiologist.
2.! Prehabilitation group
Patients in this group will follow the standard MUHC protocol of nutritional counselling in addition to a specific physical exercise program before and after surgery by kinesiologist.
Randomization
Patients will be assigned to the two groups using a computer-generated randomization process whereby brown sealed envelopes will be prepared and opened after patientsÕ consent has been signed.
Components of prehabilitation a.! Nutritional supplementation
The nutritional status of patients affected by esophageal cancer is directly influenced by the presence of cancer which has an impact on all aspects of intermediary (protein, carbohydrate, lipid, trace element, vitamin) metabolism, and by other factors such as age, adjuvant cancer therapy and stage of the disease. In addition, a patient who is undernourished before surgery has greater risk of morbidity and mortality. The primary goal of nutrition therapy during the perioperative period is thus to optimize nutrient stores pre-operatively and provide adequate nutrition to compensate for the catabolic response of surgery post-operatively. This includes preventing the loss of lean body mass which is inversely correlated with the survival of critically ill patients.
The patientsÕ nutritional status and adequacy of dietary intake will be assessed by a nutritionist using a three day food record and the Subjective Global Assessment tool. Percentage of lean body mass and fat will be measured with bioelectrical impedance. Total energy expenditure will be measured using indirect calorimetry. All patients will be provided with samples of dietary supplements as needed (including Ensure Plus, Boost Plus, Resource fruit beverage, and Beneprotein powder) and will be provided with strategies to optimize dietary energy and protein intake (in accordance with degree of dysphagia) according to current standard hospital protocols. The total amount of supplements (commercial or homemade) the patient is required to take daily will be determined on an individual basis according to the patientÕs nutritional status, including degree of dietary energy and protein deficits, as assed by the nutritionist at baseline assessment.
Compliance will be monitored weekly through phone calls by the study coordinator. The patients will also be asked to complete a journal detailing how much nutritional supplements are consumed each day.
b.! Physical exercise program
It has been shown that prehabilitation can improve postoperative physical function in cancer patients undergoing colorectal surgery and lung resection, and these changes are associated with improvements in mental health, vitality, and self-perceived health.
Moreover, it appears that subjects whose fitness deteriorated preoperatively have more surgical complications and require intensive care. A recently published systematic review of preoperative physical exercise by Valkenet et al reported less postoperative complications and shorter length of stay in abdominal surgery patients. Although the role of exercise intensity is unclear, it appears that moderate exercise, carried out in a combination of aerobic and resistance training components, is sufficient to provide adequate physiological reserve and energy, even in patients who receive chemotherapy.
At the baseline assessment all patientsÕ physical fitness will be evaluated by the kinesiologist (exercise specialist). In the prehabilitation group the exercise component will consist of 20 min of general exercise training, 3 days per week, alternating between aerobic and resistance training. The exercise program will be individualized based upon the baseline fitness test (according to the American College of Sport Medicine, ACMS, standard) and will include: a 5 min warm-up, either 25 min of aerobic exercise (starting at 30-40 of heart rate reserve, HRR), or 25 min of resistance training (5 exercises targeting major muscle groups performed at an intensity of 8-12 repetition maximum), and a 5 min cool-down. All exercises will be clearly explained and demonstrated by the kinesiologist at baseline. Patients will be asked to carry out this program at home, unsupervised, but will be monitored with weekly telephone calls. Training intensity progression will occur when the participant can complete aerobic exercise on mild exertion and/or when the participant can complete 15 repetitions of a given resistance exercise. Participants will be provided with resistance bands, an exercise mat, a pedometer, a heart rate monitor (to monitor compliance) and a log book to report frequency of exercises completed and to record all the activities.
The control group will receive general instructions on exercises during hospital stay while in bed, walking and sitting. All patients will also receive one session on inspiratory muscles training (IMT) and they will be encouraged to perform this exercise every day.
The kinesiologist will follow all the participants on a weekly basis to ensure program compliance and address any barriers that may prevent ongoing participation.
C. Psychological counseling
It is expected that patients undergoing esophageal surgery for cancer are anxious. The patients in both groups will be referred for consultation to the hospital clinical psychologist for counseling as per MUHC policy.
Procedures
To make the two groups as similar as possible, a clear explanation will be made to the patients emphasizing that both groups will be seen by the team and they will receive one booklet on clinical pathway for esophageal surgery prepared by the SURE committee of the MUHC, and a booklet with the study instructions. Both booklets have been developed at the MUHC by members of the MUHC Surgical Recovery (SuRe) clinical pathways committee in collaboration with McGill Molson Medical Informatics with the intention to explain, using many pictures and drawings, all aspects of perioperative care and guide the patient during the period of the study. In addition, patients will receive a journal/log book where all activities related to the prehabilitation will be recorded.
Measures
All measurements will be recorded at baseline (beginning of prehabilitation period), immediately prior to surgery (end of prehabilitation period) and at 4 and 8 weeks after surgery.
The primary outcome is patient-relevant, functional walking capacity as measured by the six-minute walk test (6MWT). The 6MWT evaluates the ability of an individual to maintain a moderate level of physical activity over a time period reflective of the activities of daily living. Subjects are instructed to walk back and forth, in a 20 m stretch of hallway, for six minutes, at a pace that would make them tired by the end of the walk; encouragement and feedback are given according to published guidelines. They are allowed to rest during the test if needed, but this time is included in the 6 minutes. Reference equations are available for calculating percent of age-and gender-specific norms. In community dwelling elderly, measurement error was estimated at 20 meters and this will be used as the threshold value for determining true change. The 6MWT correlates moderately with VO 2 max indicating that these two tests measure related but not identical constructs. As daily activity is mostly pursued at a sub-maximal level, functional walking capacity is a more direct measure of capacity for daily routine than a maximal test of exercise capacity such as VO 2 max and is more feasible to perform in the perioperative population. The test-retest reliability has been reported to range from 0.73 to 0.99 among a variety of populations, including the elderly. The 6MWT has been shown to be reliable and valid in many populations including surgical ones, with a recent paper from our group supporting its validity as a measure of recovery after colorectal surgery. The test will be administered at baseline, on the day before surgery to assess the effect of intervention during the prehabilitation phase, and at 4 and 8 weeks after surgery to assess the impact of the intervention throughout the perioperative period.
Secondary outcomes will include:
Health-related quality of life (HRQL) as measured by the acute (1 week recall period) SF-36 health survey. The SF-36 is the most widely used HRQL measure and has been validated for surgical population; Canadian norms are also available. It incorporates behavioural functioning, subjective well-being and perceptions of health by assessing, on a 0 to 100 scale, eight health concepts: Quality of life will be also assessed using the European Organization for Research and Treatment of Cancer (EORTC) QLQ Ðesophagus-18 questionnaire (a OLQdesigned for esophageal disease). This outcome measure has been used in esophageal cancer and shown to be reliable and has face validity. All scales range from 0 to 100. A higher score for each functional scale represents high/healthy level of functioning.
Physical activity level will be measured through the Community Health Activities Model Program for Seniors (CHAMPS) questionnaire. The CHAMPS is a self-reported measure of physical activity, comprising 41 activities evaluated according to the total number of hours done during an average week. Each physical activity is assigned a MET (metabolic equivalent) value yielding average weekly caloric expenditure for the listed physical activities. There is evidence for the validity of CHAMPS as a measure of postoperative recovery. CHAMPS will be measured at baseline, before surgery, and at 4 and 8 weeks after surgery.
Depression and anxiety will be assessed by The Hospital Anxiety and Depression Scale (HADS), a 14-question measure with seven items each for depression and anxiety. HADS generates separate scores for anxiety and depression as well as a combined score of psychological distress has been shown to have good psychometric properties for factor structure, sub-scale intercorrelation, homogeneity, and internal consistency and has been used in studies of patients with a variety of healthcare problems. Psychological tests will be used both as predictors of postoperative functional restoration, and as guides for psychological intervention. HADS ha will be measured at baseline, before surgery, and at 4 and 8 weeks after surgery.
Nutritional status will be assessed at baseline by measuring body mass index (BMI), body weight loss over the preceding three months, and serum albumin. Patients will also be assessed for malnutrition according to Subjective Global Assessment, administered by the nutritionist. Hand grip strength and body impedance will be also measured.
Postoperative complications grading, will be defined a priori according to the system proposed by Seely .
Fatigue score using the Fatigue Index.
Process measures will include adherence to the protocol (as recorded in a journal), in addition to safety.
Assessment of glutathione in blood will be measured at baseline, end of prehabilitation period, and 4 weeks after surgery. The glutathione measurement involves taking 0.5ml of blood, and will provide an index of glutathione (antioxidant) status within the body.
Assessment of CRP in blood: CRP will be assessed to provide a marker of inflammation. The measurement will be taken at the same time as the glutathione blood measurement is taken, and requires 1ml of blood.
The research assistant performing the 6MWT and helping the subjects with the questionnaires and forms will not be aware of the study hypothesis, randomization, and will not have access to the patientsÕ data.
Patients will return to the hospital at 4 weeks to see the surgeon, and will be asked to come at 8 weeks after surgery to collect the postoperative data. Patients coming to the hospital for the latter visit will be reimbursed for their expenses incurred in parking their car.
Statistical Analysis
To determine if differences exist between groups, patient characteristics will be analyzed using studentÕs t-test and chi squared test, as appropriate (i.e. categorical vs continuous variables). Measurements of the dependent variables are repeated multiple times per patient under different conditions, thus the data will be analyzed using repeated measures anova. If the data is not normally distributed, a non-parametric equivalent, FriedmanÕs Test, will be used.
Clinical pathway for perioperative care
Surgery will be performed by Dr Ferri and Dr Mulder at the Montreal General Hospital. Surgical approach, including laparoscopic or open surgery, will be at the discretion of the surgeon. Perioperative care will follow the McGill Surgical Recovery Pathway, also called Enhanced Recovery Program (ERP), which is an evidence-based care plan set up by the Surgical Recovery (SuRe) multidisciplinary committee of the McGill University Health Centre. The ERP for esophageal surgery has been operational since June 2010 and includes standardized patient education, preoperative feeding, laparoscopic approach, multimodal analgesia, maintenance of perioperative normothermia, early oral intake, early mobilization, early removal of catheters and drains, and a planned 7-day hospital stay.
Feasibility and time line
Approximately 50 esophageal cancer resections are performed annually at the Montreal General Hospital. If 75% of patients are eligible, and 75% of them agree to participate, we would enroll 1 patient each week (20 to 30 weeks for enrolment). In our institution, time from decision for surgery to the operation currently ranges from three to four weeks (it depends whether they receive neo-adjuvant chemotherapy), which will allow for the time required for prehabilitation. Thus, a period of one and a half years for completion of this project is a feasible time.
Power and sample size calculation
There is currently no data on the effect of prehabilitation for esophageal surgery on functional capacity after surgery. We therefore use an estimate based on our previous trials on prehabilitation. The estimator of effectiveness is the change in functional walking capacity from baseline 6MWT to 8 weeks after surgery. In our previous clinical trial , the control group receiving a recommendation for walking and breathing were on average -15 (66) meters below baseline. In a recent pilot trial where exercise, nutrition, and psychological care were given, patients were on average +37 (68) meters above baseline. The difference to be detected by independent t-test is thus 53 meters with pooled standard deviation of 68.5 and an effect size of 0.77. With a sample size of 56, (28 patient per group), we will have 80% power (with an alpha level of 0.05) to detect a difference of the same magnitude. Owing to differences between esophageal and colon surgery patient populations, a conservative estimate to avoid underpowering would be an effect size of 0.7, yielding a total sample size of up to 68, (34 per group).
Significance
There is a strong realization that many side effects associated with surgical stress can be attenuated, thus facilitating the recovery process. In view of the impact of cancer on physical, nutritional and psychological status, it is necessary to optimize body reserves preoperatively to prepare the patient for the stress of surgery. This study could provide some direction to guide clinicians in optimizing the perioperative period in patients undergoing esophageal surgery as well as contributing to our understanding of which outcome measures represent a valid index of recovery and are sensitive to changes. The model of esophageal surgery for cancer was chosen because of the extensive impact this cancer has on postoperative outcome, therefore determining whether a multimodal intervention, timely based, could increase preoperative reserve and therefore attenuate the surgical stress response leading to reduced postoperative complications is indicated. The results of this randomized study will form the basis for studies in other surgical conditions and aimed at optimizing the perioperative period and minimizing morbidity, thus improving recovery and quality of life in surgical patients.
Facilities available
The investigators are all located at the Montreal General Hospital. The project will be run out of the laboratory in the Department of Anesthesia at the Montreal General Hospital. This lab is equipped for physiologic measurements and staffed with a research associate, a research assistant and fellows. Computer facilities for data collection and management will be available through the Thoracic surgery patient database and Steinberg-Bernstein Centre for Minimally Invasive Surgery at the Montreal General Hospital.
Confidentiality
The information collected for the purpose of the research study will be kept strictly confidential and locked in a cupboard in a locked room. All staff, including students, have signed a confidentiality agreement. The computer where data are entered is located in a locked room and not accessible.
